| Current Price | $36.55 | Mkt Cap | $1.33B |
|---|---|---|---|
| Open | $36.70 | P/E Ratio | 0.00 |
| Prev. Close | $37.05 | Div. (Yield) | N/A (N/A) |
| Daily Range | $36.15 - $36.70 | Volume | 186,060 |
| 52-Wk Range | $24.85 - $38.85 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- Robbins Umeda LLP Announces an Investigation of Par Pharmaceutical Companies, Inc. 2/6/2012 12:01:00 PM -
- Par Pharmaceutical Companies Reaches New 52-Week High (PRX) 2/1/2012 2:00:17 PM -
- U.S. Stock Options With Biggest Changes in Implied Volatility 1/31/2012 11:30:10 AM -
- Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2011 Results on February 28, 2012 1/31/2012 9:00:00 AM -
- Get These 5 Stocks While They're Hot - Investment Ideas 1/27/2012 12:00:01 AM
- Lawsuit Alleges Walgreen, Par Pharma Overcharged For Generics 1/13/2012 10:49:59 AM
- Pozen Inks $75 Million Royalty Deal for Treximet 11/26/2011 3:21:52 PM
- Pozen Inks $75 Million Royalty Deal for Treximet 11/26/2011 3:21:52 PM
| Subject | Recs | Author | Date |
|---|


